22 May 2013
Keywords: b-ms, gains, rights, uft, anticancer, drug, bristol-myers
Article | 15 May 1995
Bristol-Myers Squibb has acquired exclusive rights in most world markets
to UFT (tegafur and uracil), an anticancer product developed by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 May 1995
22 May 1995
21 May 2013
© 2013 thepharmaletter.com